Patent · US Active

Nanofluidic devices for the rapid mapping of whole genomes and related systems and methods of analysis

US9970898B2 · kind B2 · utility

4Cited by
21References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 11, 2014
Grant dateMay 15, 2018
Priority date
Expiry dateAug 8, 2034

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01L2400/0421
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Devices and methods generate an ordered restriction map of genomic DNA extracted from whole cells, nuclei, whole chromosomes, or other sources of long DNA molecules. The devices have a fluidic microchannel that merges into a reaction nanochannel that merges into a detection nanochannel at an interface where the nanochannel diameter decreases in size by between 50% to 99%. Intact molecules of DNA are transported to the reaction nanochannel and then fragmented in the reaction nanochannel using restriction endonuclease enzymes. The reaction nanochannel is sized and configured so that the fragments stay in an original order until they are injected into the detection nanochannel. Signal at one or more locations along the detection nanochannel is detected to map fragments in the order they occur along a long DNA molecule.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.